Ascenta Therapeutics, Inc. (Ascenta), a private, US-based oncology drug development company, and Ascentage Pharma Group Corporation (APGC), a company focused on bringing novel anticancer therapeutics to the Chinese market and establishing partnerships in other markets, today announced the formation of a strategic collaboration to co-develop Ascenta's clinical stage, apoptosis-triggering small molecules, AT-101 and AT-406, in China. The agreements leverage the complementary strengths of the companies in chemistry, manufacturing, preclinical and clinical development in an effort to cost-effectively accelerate progress in ... read more
Covad Wholesale, a leading national provider of IP broadband services, and Broadvox, a recognized leader in the VoIP industry for almost a decade, announced today that the companies are extending their partnership. Broadvox will now leverage Covad's IP Backhaul Aggregation Service and Ethernet access services to deliver, prioritize and segment voice traffic to meet the demanding needs of their business customer base, which includes professional services and healthcare-related business customers.
"We've partnered with Covad Wholesale since 2007, which has enabled ... read more
VRI, a leading provider of in-home health monitoring systems, and SeniorBridge, a national health management provider, today announced a service that combines remote vital sign monitoring with face-to-face oversight from professional geriatric care managers. The program is designed to reduce hospitalizations of chronically ill seniors by identifying warnings signs early and identifying solutions to address medical, functional and psychosocial needs.
"The VRI-enabled SeniorBridge TeleCare Management program is our latest effort to address the changing needs of health plans, health professionals ... read more
CellTrust Corporation, the recognized leader in mobile secure messaging and secure applications for mobile phones (www.celltrust.com), announced today that it is partnering with NewNet, the pioneering leader in telecom infrastructure solutions (www.newnet.com) with deployments in more than 60 countries, in creating the first integrated SMSC and Secure SMS solution for mobile operators worldwide. The partnership will allow any mobile operator to integrate CellTrust's SecureSMS Appliance with NewNet's SMSC platform, to deliver a complete SMS solution to wireless subscribers.
The partnership ... read more
ROUND2 INC., a leading eRecycling service provider, is pleased to announce the release of its new corporate website. The website address, www.ROUND2.net remains the same, but the dramatically redesigned site is more user-friendly, educational and comprehensive regarding ROUND2 services.
"As our business becomes more sophisticated our website will follow suit," said Jeff Mangels, ROUND2's Director of Marketing. "The new www.ROUND2.net is bold, clean and embodies ROUND2's forward-thinking vision and commitment to the recycling needs of our clients."
ROUND2 INC. is ... read more
Bluewolf (www.bluewolf.com) today announced that its executives will lead three sessions on the company's best practices for cloud computing gleaned from its thousands of implementations at the salesforce.com annual user conference, Dreamforce, being held here next week. Bluewolf, a platinum sponsor, will be joined by partners; Corda, Five9, and PivotLink.
Beyond Go-Live: A Plan for Sustaining ROI with Salesforce
Tuesday, December 7 at 12:45 p.m. in Room West 3014
You're in the cloud -- now what? In a world ... read more
Anybody with little ones knows that New Year's Eve is the most difficult day to find a babysitter, but what most parents might not know is that the longer they wait to snag a sitter, the more they may have to pay. According to Sittercity.com, most parents wait until December 29 to find a New Year's Eve babysitter, often leading to having to pay higher rates.
New Year's Eve by the numbers according to Sittercity:
-- ... read more
Northrop Grumman Corporation (NYSE: NOC) announced today the results of the cash tender offer for any and all of an aggregate $200 million of 4.55% Gulf Opportunity Zone Industrial Development Revenue Bonds due December 1, 2028 (GoZone bonds) on the terms and conditions set forth in the Offer to Purchase dated November 1, 2010, and related Letter of Transmittal. The tender offer expired at 11:59 p.m., New York City time, on November 30, 2010. As of the expiration ... read more
MICROS-Retail, a division of MICROS Systems, Inc. (Nasdaq: MCRS), and leading provider of retail technology for the specialty and general merchandise retail industry, is pleased to announce the launch of a new web site for Legendary Whitetails, a retailer of casual apparel, gifts and gear for whitetail hunters. The new site was built on MICROS-Retail's Open Commerce Express, a new e-commerce offering based on the Open Commerce Platform(TM) (OCP) designed and developed by Fry, Inc., a MICROS-Retail company.
Legendary Whitetails ... read more
Acclaimed comedian and actor Jon Lovitz is talking candidly for the first time about living with severe plaque psoriasis through a national disease awareness campaign called Are You Serious?(TM). Psoriasis is a chronic autoimmune condition which causes red, scaly plaques on the skin and affects nearly 7.5 million Americans, including Lovitz, who struggled with the condition for 10 years before getting its symptoms under control. Through his distinctive comedic style, Lovitz illustrates several of the everyday challenges faced by ... read more
Varian Medical Systems (NYSE: VAR) announced today that its Board of Directors has set the regular 2011 Annual Meeting of Stockholders for February 10, 2011 with a record date of December 15, 2010. The meeting will be held at Varian's corporate headquarters, 3100 Hansen Way, Palo Alto, CA 94304 at 4:30 p.m. PT.
The meeting will be webcast and can be accessed at Varian Medical Systems' website at http://www.varian.com/investor. To attend the meeting, please RSVP to Anne Rambo, at 650-424-5834, or ... read more
China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, is scheduled to present at the CLSA Emerging Markets Pharma Conference in New York. Details for the conference are as follows:
Conference: CLSA Emerging Markets Pharma Conference
... read more
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although Amgen/Pfizer/Stiefel's Enbrel will remain the most-prescribed first-line biologic for moderate-to-severe psoriasis, it will lose market share at this line of therapy to agents in the IL-12/IL-23 inhibitors drug class, namely Centocor Ortho Biotech/Janssen-Cilag's Stelara. Surveyed U.S. dermatologists estimate that among moderate-to-severe psoriasis patients who currently initiate biologic therapy, approximately half receive Enbrel and more than one-third receive Abbott/Eisai's Humira.
The new U.S. ... read more
Ann Taylor Stores Corporation (NYSE: ANN) raised an unprecedented $2.6 million for The Breast Cancer Research Foundation® (BCRF) through their ANN Cares® Card and LOFT Cares® Card programs and products. The custom designed products included the ANN Cares Bracelet & Necklace designed by Lisa Axelson, and the LOFT Cares Jewelry Collaborations with designers Anna Sheffield, Kara Ross, and Robin Renzi of Me&Ro. The donation will fully fund ten BCRF research projects in the 2011-2012 grant making period.
The Company's ... read more
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in the 5th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference on Tuesday, December 7.
The presentation by John Dahldorf, chief financial officer, will begin at 11:30 a.m., Pacific Standard Time (2:30 p.m., Eastern Standard Time).
The presentation will be available through the conference website at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3298900 ... read more
A new study shows the SCOLISCORE(TM) AIS Prognostic Test, a DNA test to determine the likelihood of curve progression in children with mild adolescent idiopathic scoliosis (AIS), an abnormal curvature of the spine, is 99 percent accurate in predicting which children are least likely to progress to a severe curve (Cobb Angle of 40 degrees or more).(1)
Researchers analyzed DNA samples and medical records of nearly 700 patients from over 100 clinical sites throughout the United States. Their findings appear in ... read more
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the Chinese type 2 diabetes market will grow from $1.4 billion in 2009 to $2.5 billion in 2014. According to the Emerging Markets report entitled Type 2 Diabetes in China, this growth is attributed to an increasing drug-treated population, expanding medical insurance coverage and the launch and adoption of new drugs in the market.
"China now has the largest type 2 diabetes patient ... read more
Data published in the December issue of the medical journal Muscle and Nerve confirm the utility of six-minute walk distance (6MWD) as a clinically meaningful endpoint in dystrophinopathy, a disease continuum comprising Duchenne and Becker muscular dystrophy (DBMD). The data showed that boys with DBMD experience a significant decline in walking ability compared to healthy boys over one year, suggesting that slowing the loss of walking ability is a major treatment goal. The observational study, which provides the ... read more
Watson Pharmaceuticals, Inc. (NYSE: WPI), announced today that ella® (ulipristal acetate) 30 mg, a novel oral emergency contraceptive, is now available for patients by prescription in the U.S. ella® was approved by the U.S. Food and Drug Administration (FDA) as safe and effective in helping to prevent unintended pregnancy for up to five days after unprotected intercourse (UPI) or a known contraceptive failure. ella® delays ovulation for up to five days, which is also the length of time ... read more
Bluewolf (www.bluewolf.com) announced today that it will hold its Second Annual Women Innovators Network Luncheon. The event will recognize female executives who have demonstrated extraordinary vision and leadership by implementing new technologies that have helped their organizations become more agile and competitive--especially during lean times. Bluewolf has helped businesses successfully deploy cloud computing solutions for more than a decade.
Sponsored by salesforce.com and Eloqua, the Second Annual Bluewolf Women Innovators Network Luncheon will be held on Tuesday, December 7, 11:45 ... read more